Intraoperative Protective Ventilation and Postoperative Pulmonary Complications

February 6, 2019 updated by: Marcos Vidal Melo, Massachusetts General Hospital
The purpose of this pilot study is to identify the optimal way to ventilate patients during abdominal surgery in order to reduce the amount of post-operative pulmonary complications in patients at moderate and high-risk for them.

Study Overview

Detailed Description

The investigators plan to prospectively compare two methods to individualize Positive End Expiratory Pressure (PEEP) settings in the operating room during abdominal surgery: (1) Maximization of respiratory compliance during a decremental PEEP titration, and (2) Prevention of negative end-expiratory transpulmonary pressures.

The investigators will exploit the usual intraoperative requirement for a naso/orogastric tube to assess transpulmonary pressures,and respiratory mechanics measurements from anesthesia machines to titrate PEEP.

The investigators will measure biomarkers of lung injury and lung function to compare those methods between themselves and to the control group. In the process, the investigators will assess the ease and reliability of anesthesia teams in implementing the methods. These data will allow us to determine the PEEP strategy best suited for the full-scale trial, and to estimate the degree of separation the experimental lung protective approach will have from the protocolized usual care control settings.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02114
        • Massachusetts General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adults ( 18 years) scheduled for elective surgery expected to last 2 h,
  • elective intraperitoneal abdominal or pelvic surgery including: gastric; biliary; pancreatic; hepatic; major bowel, ovarian, renal tract, bladder, and prostatic; radical hysterectomy; and pelvic exenteration;
  • at least intermediate risk of PPCs defined by a risk score 26

Exclusion Criteria:

  • Inability or refusal to provide consent
  • Refusal of clinicians caring for patient to follow the protocol
  • Participation in interventional investigation within 30 days of the time of the study
  • Pregnancy
  • Emergency surgery
  • Severe obesity (above Class I, BMI 35)
  • Significant lung disease: any diagnosed or treated respiratory condition that (a) requires home oxygen therapy or non-invasive ventilation, (b) severely limits exercise tolerance to <4 METs (e.g. patients unable to do light housework, walk flat at 4 miles/h or climb one flight of stairs), or (c) required previous lung surgery80
  • Significant heart disease: cardiac conditions that limit exercise tolerance to <4 METs
  • Renal failure: peritoneal or hemodialysis requirement or preoperative creatinine 2 mg/dL;
  • Neuromuscular disease that impairs ability to ventilate without assistance
  • Severe chronic liver disease (Child-Pugh Score of 10 -15)
  • Sepsis
  • Malignancy or other irreversible condition for which 6-month mortality is estimated 50%
  • Bone marrow transplant.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Conventional Strategy
Patients will receive usual and prudent PEEP and tidal volume settings.
Experimental: Maximal Compliance Strategy
PEEP will be set at the maximum static respiratory system compliance during a descending PEEP titration curve.
PEEP will be set at the maximum static respiratory system compliance during a descending PEEP titration curve.
Experimental: Transpulmonary Pressure Strategy
Personal PEEP titration using transpulmonary pressures obtained from a naso/orogastric tube containing an esophageal balloon port
We will use transpulmonary pressure values obtained using an naso/orogastric tube during the operative procedure to titrate PEEP intraoperatively.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intraoperative driving pressure
Time Frame: During abdominal surgery
We will assess intraoperative driving pressure to evaluate respiratory mechanics during surgery.
During abdominal surgery
Intraoperative transpulmonary pressure
Time Frame: During abdominal surgery
We will assess intraoperative transpulmonary pressure to evaluate respiratory mechanics during surgery.
During abdominal surgery
Intraoperative respiratory system compliance
Time Frame: During abdominal surgery
We will assess intraoperative respiratory system compliance to evaluate respiratory mechanics during surgery.
During abdominal surgery
Intraoperative positive end-expiratory pressure (PEEP) levels
Time Frame: During abdominal surgery
We will assess intraoperative PEEP values and their variability between patients and during surgery.
During abdominal surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intraoperative gas exchange
Time Frame: During abdominal surgery
We will assess intraoperative oxygenation and carbon dioxide elimination.
During abdominal surgery
Plasma levels of biomarkers of lung injury
Time Frame: During abdominal surgery
We will assess plasma concentrations of biomarkers of lung injury before and after surgery, including biomarkers of inflammation (interleukin-6, IL-6, interleukin-8, IL-8), epithelial injury (soluble form of the receptor for advanced glycation end-products, sRAGE, Club Cell protein-16, CC16), endothelial injury (angiopoietin-2, Ang-2), and endothelial-derived coagulation activation (plasminogen activator inhibitor-1, PAI-1).
During abdominal surgery
Postoperative Pulmonary Complications
Time Frame: Within the first 7 postoperative days.
We will assess the incidence and absolute number of postoperative pulmonary complications within the first 7 postoperative days.
Within the first 7 postoperative days.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2016

Primary Completion (Actual)

March 1, 2017

Study Completion (Actual)

June 1, 2017

Study Registration Dates

First Submitted

January 30, 2016

First Submitted That Met QC Criteria

January 30, 2016

First Posted (Estimate)

February 2, 2016

Study Record Updates

Last Update Posted (Actual)

February 8, 2019

Last Update Submitted That Met QC Criteria

February 6, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 2015P001613

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Respiratory Complications

Clinical Trials on Maximal Compliance

3
Subscribe